Neuralink, the brain-chip startup founded by Elon Musk, has officially launched its first clinical trial in the Middle East, known as UAE-PRIME. This trial will take place at Cleveland Clinic Abu Dhabi in partnership with the Department of Health – Abu Dhabi (DoH). Abu Dhabi will be the first international site outside of North America...
The Department of Health – Abu Dhabi (DoH) and the Abu Dhabi Investment Office (ADIO) have announced a partnership with Unilabs Pharma Solutions to establish an analytical laboratory. This initiative is part of the newly launched ‘Health, Endurance, Longevity, and Medicine’ cluster, aimed at enhancing various aspects of healthcare in the region. Under a memorandum...
UAE-based Autogo, a company specializing in autonomous mobility solutions, has officially launched trials for its RoboTaxi service in Abu Dhabi. The full operations of this service are expected to commence by 2026. This initiative is part of a strategic partnership with Apollo, a company owned by Baidu that is a leading provider of large-scale autonomous...
Medicus Pharma has filed a clinical design with the United Arab Emirates Department of Health aimed at non-invasively treating Basal Cell Carcinoma (BCC), a type of skin cancer. The study is set to evaluate the effectiveness of two dose levels of D-MNA in comparison to a placebo control. In the initial study, known as SKNJCT-001,...
A recent study has revealed that Sotagliflozin, a drug approved by the US Food and Drug Administration (FDA) for treating type 2 diabetes, can also significantly lower the risk of heart attacks and strokes. This finding came from an international clinical trial that involved over 10,000 participants and highlighted the drug’s additional benefits in reducing...